Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,587,401
-$263,688 QoQ
Shares Held
65,922
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,069
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WENDELL DAVID ASSOCIATES INC holds $121,005,454 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
44,419 | $53,277,485 | |
| 2 | JNJ |
Johnson & Johnson
|
100,552 | $25,537,191 | |
| 3 | ABBV |
AbbVie Inc.
|
96,228 | $24,214,813 | |
| 4 | MRK |
Merck & Co., Inc.
|
56,376 | $7,244,316 | |
| 5 | AMGN |
Amgen Inc
|
10,743 | $3,890,255 | |
| 6 | NVO |
Novo Nordisk A S
|
59,058 | $2,831,240 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13,440 | $1,698,009 | |
| 8 | PFE |
Pfizer Inc
This page
|
65,922 | $1,587,401 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,587,401 | 65,922 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $1,851,089 | 65,922 | Shares | Other | 2026-04-23 | |
| 2025-12-31 | $1,509,612 | 60,627 | Shares | Other | 2026-01-30 | |
| 2025-09-30 | $1,469,864 | 57,687 | Shares | Other | 2025-10-30 | |
| 2025-06-30 | $1,382,576 | 57,037 | Shares | Other | 2025-07-29 | |
| 2025-03-31 | $1,491,436 | 58,857 | Shares | Other | 2025-04-18 | |
| 2024-12-31 | $1,551,845 | 58,494 | Shares | Other | 2025-01-17 | |
| 2024-09-30 | $1,721,409 | 59,482 | Shares | Other | 2024-10-21 | |
| 2024-06-30 | $1,631,038 | 58,293 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $1,606,530 | 57,893 | Shares | Other | 2024-04-22 | |
| 2023-12-31 | $1,736,238 | 60,307 | Shares | Other | 2024-01-22 | |
| 2023-09-30 | $2,000,383 | 60,307 | Shares | Other | 2023-10-20 | |
| 2023-06-30 | $2,107,779 | 57,464 | Shares | Other | 2023-07-20 | |
| 2023-03-31 | $2,345,755 | 57,494 | Shares | Other | 2023-04-19 | |
| 2022-12-31 | $2,882,967 | 56,264 | Shares | Other | 2023-01-17 | |
| 2022-09-30 | $2,441,107 | 55,784 | Shares | Other | 2022-10-18 | |
| 2022-06-30 | $2,906,404 | 55,434 | Shares | Other | 2022-07-14 | |
| 2022-03-31 | $2,870,750 | 55,452 | Shares | Other | 2022-04-22 | |
| 2021-12-31 | $3,274,440 | 55,452 | Shares | Other | 2022-01-24 | |
| 2021-09-30 | $2,384,216 | 55,434 | Shares | Other | 2021-10-19 | |
| 2021-06-30 | $2,170,795 | 55,434 | Shares | Other | 2021-07-19 | |
| 2021-03-31 | $2,008,373 | 55,434 | Shares | Other | 2021-04-20 | |
| 2020-12-31 | $2,069,973 | 56,234 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $2,059,124 | 56,107 | Shares | Other | 2020-10-20 | |
| 2020-06-30 | $1,802,000 | 55,107 | Shares | Other | 2020-07-17 | |
| 2020-03-31 | $1,798,690 | 55,107 | Shares | Other | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||